Scientia Vascular

Scientia Vascular

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $12.5M

Overview

Scientia Vascular is an innovative neurovascular medical device company that has developed a patented microfabrication platform to manufacture next-generation guidewires and catheters. Its technology, which involves precision laser-cutting of nitinol hypotubes to create microfeatures, aims to solve historical limitations in torque control, flexibility, and support, thereby improving procedural efficiency and outcomes in treating diseases like stroke and aneurysms. The company appears to be in a commercial or early revenue stage, actively marketing its products to hospitals and physicians while continuing to grow its team. Positioned in the high-growth neurovascular intervention market, Scientia's success hinges on clinical adoption, competition with established players, and its ability to scale manufacturing and commercial operations.

NeurovascularCardiovascular

Technology Platform

Proprietary microfabrication process using precision laser-cutting of nitinol hypotubes to create devices with microfeatures (rings, beams) for superior torque control, tunable flexibility, and structural integrity in neurovascular guidewires and catheters.

Funding History

2
Total raised:$12.5M
Series A$10M
Seed$2.5M

Opportunities

The company operates in the high-growth neurovascular intervention market, driven by an aging population and increased adoption of minimally invasive stroke treatments.
Its patented microfabrication technology offers demonstrable performance advantages in control and access, positioning it to capture market share from established competitors by meeting unmet needs in complex procedures.

Risk Factors

Key risks include intense competition from large, well-funded medical device conglomerates with broad portfolios and strong physician relationships.
Successful commercialization depends on overcoming clinical adoption barriers and scaling manufacturing and sales operations effectively in a conservative market.

Competitive Landscape

Scientia Vascular competes in the neurovascular access device market against major global players like Medtronic, Stryker, Johnson & Johnson, and Terumo. These competitors have extensive product lines, significant R&D budgets, and established distribution channels. Scientia's differentiation is its niche focus on advanced microfabrication technology for superior device performance.